A novel urinary biomarker predicts 1-year mortality after discharge from intensive care

Esther Nkuipou-Kenfack, Agnieszka Latosinska, Wen-Yi Yang, Marie-Celine Fournier, Alice Blet, Blerim Mujaj, Lutgarde Thijs, Elodie Feliot, Etienne Gayat, Harald Mischak, Jan A. Staessen, A. Mebazaa, Zhen-Yu Zhang*, N. Deye, C. Fauvaux, A. Mebazaa, C. Damoisel, D. Payen, E. Azoulay, A. S. MoreauL. Jacob, O. Marie, M. Wolf, R. Sonneville, R. Bronchard, I. Rennuit, C. Paugam, J. P. Mira, A. Cariou, A. Tesnieres, N. Dufour, N. Anguel, L. Guerin, J. Duranteau, C. Ract, M. Leone, B. Pastene, T. Sharshar, A. Fayssoyl, J. L. Baudel, B. Guidet, Q. Lu, W. Jie Gu, N. Brechot, A. Combes, S. Jaber, A. Pradel, Y. Coisel, M. Conseil, A. Vieillard-Baron, French European Outcome Registry

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)

Abstract

Rationale The urinary proteome reflects molecular drivers of disease. Objectives To construct a urinary proteomic biomarker predicting 1-year post-ICU mortality. Methods In 1243 patients, the urinary proteome was measured on ICU admission, using capillary electrophoresis coupled with mass spectrometry along with clinical variables, circulating biomarkers (BNP, hsTnT, active ADM, and NGAL), and urinary albumin. Methods included support vector modeling to construct the classifier, Cox regression, the integrated discrimination (IDI), and net reclassification (NRI) improvement, and area under the curve (AUC) to assess predictive accuracy, and Proteasix and protein-proteome interactome analyses. Measurements and main results In the discovery (deaths/survivors, 70/299) and test (175/699) datasets, the new classifier ACM128, mainly consisting of collagen fragments, yielding AUCs of 0.755 (95% CI, 0.708-0.798) and 0.688 (0.656-0.719), respectively. While accounting for study site and clinical risk factors, hazard ratios in 1243 patients were 2.41 (2.00-2.91) for ACM128 (+ 1 SD), 1.24 (1.16-1.32) for the Charlson Comorbidity Index (+ 1 point), and >= 1.19 (P = + 0.50), NRI (>= + 53.7), and AUC (>= + 0.037) over and beyond clinical risk indicators and other biomarkers. Interactome mapping, using parental proteins derived from sequenced peptides included in ACM128 and in silico predicted proteases, including/excluding urinary collagen fragments (63/35 peptides), revealed as top molecular pathways protein digestion and absorption, lysosomal activity, and apoptosis. Conclusions The urinary proteomic classifier ACM128 predicts the 1-year post-ICU mortality over and beyond clinical risk factors and other biomarkers and revealed molecular pathways potentially contributing to a fatal outcome.

Original languageEnglish
Article number10
Number of pages11
JournalCritical Care
Volume24
Issue number1
DOIs
Publication statusPublished - 9 Jan 2020

Keywords

  • Biomarker
  • Intensive care medicine
  • Heart failure
  • Mortality
  • Urinary proteomics
  • GELATINASE-ASSOCIATED LIPOCALIN
  • BRAIN NATRIURETIC PEPTIDE
  • ACUTE KIDNEY INJURY
  • UNIT ADMISSION
  • TERMINAL PRO
  • SOLUBLE ST2
  • PROTEOME
  • DISEASE
  • DIAGNOSIS
  • NGAL

Cite this